188627-80-7

China cas 188627-80-7 factory wholesale Eptifibatide at affordable price. Hangzhou Shanyi Biotechnology Co., Ltd. is headquartered in Hangzhou, China. It is a high-tech enterprise specializing in the research and development, production, development, and trade of chemical product technology. Our business serves local customers and markets worldwide. The company has over 30 years of chemical experience in intermediate fields such as dyes, pesticides, and pharmaceuticals. The company adheres to the cooperation philosophy of "honest cooperation, customer first". By actively listening to customer feedback and meeting their needs, the company can establish stable customer relationships and continuously improve customer satisfaction, which helps the company establish a good reputation and image in the market. With the continuous advancement of technology and changes in the market, the chemical industry is facing new opportunities and challenges. Hangzhou Shanyi Biotechnology Co., Ltd., with its rich experience, strong research and development capabilities, and customer-oriented business philosophy, continues to provide reliable quality assurance for chemical enterprises and constantly expands new business areas and market space.

What is the Eptifibatide ?

Eptifibatide is a platelet inhibitor that prevents blood clots from forming in the arteries of the heart. It's used to treat unstable angina, non-ST elevation myocardial infarction (NSTEMI), and patients undergoing percutaneous coronary intervention (PCI). Eptifibatide works by binding to platelet receptor glycoprotein and preventing fibrinogen, von Willebrand factor, and other adhesive ligands from binding to it.

China cas 188627-80-7 factory wholesale Eptifibatide at affordable price

Hangzhou Shanyi Biotechnology Co., Ltd. is a quality supplier and manufacturer of Eptifibatide . You can buy high quality, low price Eptifibatide 188627-80-7 here.

Started in August 2000 at a private dye production enterprise in Xiaoshan, Hangzhou
In March 2003, the first research and development laboratory was established, and the first dye project was successfully transformed from small-scale trial to large-scale production.
In February 2019, the first pharmaceutical intermediate related laboratory was established in Xuzhou for customized synthesis of various pharmaceutical intermediates.
In June 2022, we will officially shift from domestic trade to foreign trade, with a focus on promoting projects related to pharmaceutical intermediates and cosmetic intermediates.